Drug
Thymosin beta 4
Thymosin beta 4 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 75.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
133%(4 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_2
4
80%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
4(80.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
60.0%
3 of 5 finished
Non-Completion Rate
40.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(2)
Detailed Status
Completed3
Terminated1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (20.0%)
Phase 24 (80.0%)
Trials by Status
terminated120%
withdrawn120%
completed360%
Recent Activity
0 active trials
Showing 5 of 5
withdrawnphase_1
A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers
NCT00743769
completedphase_2
Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye
NCT01387347
terminatedphase_2
A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
NCT00311766
completedphase_2
Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers
NCT00832091
completedphase_2
Study of Thymosin Beta 4 in Patients With Pressure Ulcers
NCT00382174
Clinical Trials (5)
Showing 5 of 5 trials
NCT00743769Phase 1
A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers
NCT01387347Phase 2
Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye
NCT00311766Phase 2
A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
NCT00832091Phase 2
Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers
NCT00382174Phase 2
Study of Thymosin Beta 4 in Patients With Pressure Ulcers
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5